These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12165804)

  • 21. Relationship of epithelial ovarian cancer to other malignancies within families.
    Schildkraut JM; Thompson WD
    Genet Epidemiol; 1988; 5(5):355-67. PubMed ID: 3215509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The need for oncogenetic counselling. Ten years' experience of a regional oncogenetic clinic.
    Henriksson K; Olsson H; Kristoffersson U
    Acta Oncol; 2004; 43(7):637-49. PubMed ID: 15545184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chances and risks of prevention in elderly people for the three major cancers: breast-, prostate- and colorectal cancers].
    Kolb GF
    Zentralbl Gynakol; 2006 Jun; 128(3):123-8. PubMed ID: 16758377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.
    Kauff ND; Mitra N; Robson ME; Hurley KE; Chuai S; Goldfrank D; Wadsworth E; Lee J; Cigler T; Borgen PI; Norton L; Barakat RR; Offit K
    J Natl Cancer Inst; 2005 Sep; 97(18):1382-4. PubMed ID: 16174860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial aggregation of tumors in the three-year experience of a population-based colorectal cancer registry.
    Ponz de Leon M; Sassatelli R; Sacchetti C; Zanghieri G; Scalmati A; Roncucci L
    Cancer Res; 1989 Aug; 49(15):4344-8. PubMed ID: 2743323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.
    Leu M; Reilly M; Czene K
    J Natl Cancer Inst; 2008 Sep; 100(18):1318-25. PubMed ID: 18780865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Segregation analysis of 389 Icelandic pedigrees with Breast and prostate cancer.
    Baffoe-Bonnie AB; Kiemeney LA; Beaty TH; Bailey-Wilson JE; Schnell AH; Sigvaldason H; Olafsdóttir G; Tryggvadóttir L; Tulinius H
    Genet Epidemiol; 2002 Nov; 23(4):349-63. PubMed ID: 12432503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.
    van Asperen CJ; Brohet RM; Meijers-Heijboer EJ; Hoogerbrugge N; Verhoef S; Vasen HF; Ausems MG; Menko FH; Gomez Garcia EB; Klijn JG; Hogervorst FB; van Houwelingen JC; van't Veer LJ; Rookus MA; van Leeuwen FE;
    J Med Genet; 2005 Sep; 42(9):711-9. PubMed ID: 16141007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BRCA1 mutations and polymorphisms in a hospital-based consecutive series of breast cancer patients from Apulia, Italy.
    Tommasi S; Crapolicchio A; Lacalamita R; Bruno M; Monaco A; Petroni S; Schittulli F; Longo S; Digennaro M; Calistri D; Mangia A; Paradiso A
    Mutat Res; 2005 Oct; 578(1-2):395-405. PubMed ID: 16026807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.
    Antoniou AC; Durocher F; Smith P; Simard J; Easton DF;
    Breast Cancer Res; 2006; 8(1):R3. PubMed ID: 16417652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
    Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D
    Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.
    Risch HA; McLaughlin JR; Cole DE; Rosen B; Bradley L; Fan I; Tang J; Li S; Zhang S; Shaw PA; Narod SA
    J Natl Cancer Inst; 2006 Dec; 98(23):1694-706. PubMed ID: 17148771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for large rearrangements of the BRCA2 gene in Spanish families with breast/ovarian cancer.
    Gutiérrez-Enríquez S; de la Hoya M; Martínez-Bouzas C; Sanchez de Abajo A; Ramón y Cajal T; Llort G; Blanco I; Beristain E; Díaz-Rubio E; Alonso C; Tejada MI; Caldés T; Diez O
    Breast Cancer Res Treat; 2007 May; 103(1):103-7. PubMed ID: 17063271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Family history of breast and ovarian cancer among breast-cancer patients in the Connecticut Tumor Registry.
    Polednak AP; Flannery JT
    Conn Med; 1996 Feb; 60(2):67-73. PubMed ID: 8820629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endometriosis related to family history of malignancies in the Yale series.
    Matalliotakis IM; Cakmak H; Krasonikolakis GD; Dermitzaki D; Fragouli Y; Vlastos G; Arici A
    Surg Oncol; 2010 Mar; 19(1):33-7. PubMed ID: 19299121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population prevalence of first- and second-degree family history of breast and ovarian cancer.
    Moghimi-Dehkordi B; Safaee A; Vahedi M; Pourhoseingholi MA; Pourhoseingholi A; Zali MR
    East Afr J Public Health; 2011 Dec; 8(4):275-7. PubMed ID: 23120936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies to control cancer through genetics.
    Berg K
    Princess Takamatsu Symp; 1987; 18():283-94. PubMed ID: 3333497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer control by family history.
    Weber W
    Anticancer Res; 1993; 13(4):1197-201. PubMed ID: 8352544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promoting cancer screening among the first-degree relatives of breast and colorectal cancer patients: the design of two randomized trials.
    Marcus AC; Ahnen D; Cutter G; Calonge N; Russell S; Sedlacek SM; Wood M; Manchester D; Fox L; McCaskill-Stevens W; Fairclough D; Hines S; Wenzel L; Osborn K
    Prev Med; 1999 Mar; 28(3):229-42. PubMed ID: 10072740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hereditary cancer and its clinical implications: a view.
    Den Otter W; Koten JW; Van der Vegt BJ; Beemer FA; Boxma OJ; De Graaf PW; Derkinderen DJ; Hill FW; Huber J; Klein WR
    Anticancer Res; 1990; 10(2B):489-95. PubMed ID: 2190527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.